| Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 R Lozano, M Naghavi, K Foreman, S Lim, K Shibuya, V Aboyans, ... The lancet 380 (9859), 2095-2128, 2012 | 17985 | 2012 |
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11286 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 10203 | 2012 |
| The state of US health, 1990-2010: burden of diseases, injuries, and risk factors CJL Murray, J Abraham, MK Ali, M Alvarado, C Atkinson, LM Baddour, ... Jama 310 (6), 591-606, 2013 | 3120 | 2013 |
| Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 ER Dorsey, A Elbaz, E Nichols, N Abbasi, F Abd-Allah, A Abdelalim, ... The Lancet Neurology 17 (11), 939-953, 2018 | 2049 | 2018 |
| Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 JA Salomon, T Vos, DR Hogan, M Gagnon, M Naghavi, A Mokdad, ... The Lancet 380 (9859), 2129-2143, 2012 | 1560 | 2012 |
| Current and projected future economic burden of Parkinson’s disease in the US W Yang, JL Hamilton, C Kopil, JC Beck, CM Tanner, RL Albin, ... npj Parkinson's Disease 6 (1), 15, 2020 | 324 | 2020 |
| Longitudinal study of normal cognition in Parkinson disease K Pigott, J Rick, SX Xie, H Hurtig, A Chen-Plotkin, JE Duda, JF Morley, ... Neurology 85 (15), 1276-1282, 2015 | 282 | 2015 |
| Sex differences in Parkinson's disease and other movement disorders KM Smith, N Dahodwala Experimental neurology 259, 44-56, 2014 | 207 | 2014 |
| Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ... Jama 313 (6), 584-593, 2015 | 171 | 2015 |
| Genetic influences on cognitive decline in Parkinson's disease JF Morley, SX Xie, HI Hurtig, MB Stern, A Colcher, S Horn, N Dahodwala, ... Movement disorders 27 (4), 512-518, 2012 | 169 | 2012 |
| Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health JG Goldman, BA Vernaleo, R Camicioli, N Dahodwala, RD Dobkin, T Ellis, ... npj Parkinson's Disease 4 (1), 19, 2018 | 166 | 2018 |
| Racial differences in the diagnosis of Parkinson's disease N Dahodwala, A Siderowf, M Xie, E Noll, M Stern, DS Mandell Movement Disorders 24 (8), 1200-1205, 2009 | 133 | 2009 |
| Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial L Neurol Lancet Neurol 14 (8), 795-803, 2015 | 128 | 2015 |
| Conversion between mini‐mental state examination, montreal cognitive assessment, and dementia rating scale‐2 scores in Parkinson's disease I van Steenoven, D Aarsland, H Hurtig, A Chen‐Plotkin, JE Duda, J Rick, ... Movement Disorders 29 (14), 1809-1815, 2014 | 126 | 2014 |
| Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients CE Hill, LJ Blank, D Thibault, KA Davis, N Dahodwala, B Litt, AW Willis Neurology 92 (1), e9-e18, 2019 | 109 | 2019 |
| Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross … T Simuni, L Uribe, HR Cho, C Caspell-Garcia, CS Coffey, A Siderowf, ... The Lancet Neurology 19 (1), 71-80, 2020 | 106 | 2020 |
| Analysis of the treatment of neuromyelitis optica J Torres, A Pruitt, L Balcer, S Galetta, C Markowitz, N Dahodwala Journal of the neurological sciences 351 (1-2), 31-35, 2015 | 99 | 2015 |
| Integrated care in Parkinson's disease: a systematic review and meta‐analysis R Rajan, L Brennan, BR Bloem, N Dahodwala, J Gardner, JG Goldman, ... Movement Disorders 35 (9), 1509-1531, 2020 | 92 | 2020 |
| Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. GB Phillips, CH Tuck, TY Jing, B Boden-Albala, IF Lin, N Dahodwala, ... Diabetes care 23 (1), 74-79, 2000 | 84 | 2000 |
